Metastatic Malignant Neoplasm in the Liver Clinical Trials

22 clinical trials for Metastatic Malignant Neoplasm in the Liver across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial — RECRUITING · PHASE3
• Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies — RECRUITING · PHASE1
• An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response — RECRUITING · NA
• Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors — RECRUITING · PHASE4
• AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease — RECRUITING · PHASE1
• Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy — RECRUITING · PHASE2
• Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors — RECRUITING · PHASE2
• Local Liver Treatment for Multi-organ Colorectal Cancer Metastases — RECRUITING · NA
• Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer — TERMINATED · PHASE1
• Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival — COMPLETED · PHASE2
• Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver — COMPLETED · PHASE2
• Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions — ACTIVE_NOT_RECRUITING · NA
• Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function — TERMINATED · PHASE1
• HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization — NOT_YET_RECRUITING · PHASE2
• Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases — ACTIVE_NOT_RECRUITING · PHASE2
• Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery — TERMINATED · PHASE2
• Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases — TERMINATED · PHASE2
• Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases — ACTIVE_NOT_RECRUITING · PHASE2
• Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction — COMPLETED · PHASE1
• Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma — OTHER · PHASE1
• MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer — COMPLETED · PHASE1
• 4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis — COMPLETED

Refine this search